TrialJournal of Crohn's & colitis2024

Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial.

Andres J Yarur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.